About: Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.45 (-4.61%)
ENVB NASDAQ Enveric Biosciences Inc
Enveric Biosciences Inc share price
ENVB price activity
Last Price
$1.450
Change (24hr)
-0.07 USD (-4.61%)
Volume
50.17K
Volume (4w avg)
-
Open
$1.46
Day Range
$1.44 - $1.50
Previous Close
$1.52
Last Trade
09 Oct, 8:00 pm GMT+0
Delayed
09 Oct, 8:00 pm GMT+0
ENVB price performance
Delayed
09 Oct, 8:00 pm GMT+0
ENVB Market Signals